VICTORIA CASE: Open Payments
NPI 1205824075 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 31 payments from 6 companies in 2025. Trend: 2023 $1,280 · 2024 $572 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $206 |
| ABBVIE INC. | 12 | $172 |
| Cala Health, Inc. | 1 | $46 |
| Exact Sciences Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: AUSTEDO XR, QULIPTA, Cala kIQ, UBRELVY, BOTOX, Cologuard Collection Kit, AMYVID, INGREZZA.
Industry payments across PA — which companies pay providers there.
